Animal Models And Therapeutic Molecules - EP3622813

The patent EP3622813 was granted to Kymab on Jun 19, 2024. The application was originally filed on Jul 7, 2010 under application number EP19207050A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3622813

KYMAB
Application Number
EP19207050A
Filing Date
Jul 7, 2010
Status
Patent Maintained As Amended
May 17, 2024
Grant Date
Jun 19, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

REGENERON PHARMACEUTICALSFeb 18, 2021J A KEMPWITHDRAWN

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS5859307
DESCRIPTIONWO0104288
DESCRIPTIONWO2007117410
DESCRIPTIONWO2010039900
DESCRIPTIONWO9929837
OPPOSITIONUS2012204278
OPPOSITIONUS7205148
OPPOSITIONWO02066630
OPPOSITIONWO2007117410
OPPOSITIONWO2009013620
OPPOSITIONWO2009076464
OPPOSITIONWO2010039900
OTHEREP2517556
SEARCHUS2006015957
SEARCHWO02066630
SEARCHWO2007117410

Non-Patent Literature (NPL) Citations (82) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- CHAN, W.COSTANTINO, N.LI, R.LEE, S.C.SU, Q.MELVIN, D.COURT, D.L.LIU, P., "A recombineering based approach for high-throughput conditional knockout targeting vector construction", Nucleic Acids Research, (20070000), vol. 35, page e64-
DESCRIPTION- CHUNG, Y.J.JONKERS, J.KITSON, H.FIEGLER, H.HUMPHRAY, S.SCOTT, C.HUNT, S.YU, Y.NISHIJIMA, I.VELDS, A. et al., "A whole-genome mouse BAC microarray with 1-Mb resolution for analysis of DNA copy number changes by array comparative genomic hybridization", Genome research, (20040000), vol. 14, pages 188 - 196-
DESCRIPTION- OSOEGAWA K, Genome Research, (20010000), vol. 11, pages 483 - 496-
DESCRIPTION- PASQUALINIARAP, Proceedings of the National Academy of Sciences, (20040000), vol. 101, pages 257 - 259-
DESCRIPTION- PROSSER, H.M. et al., "Mosaic complementation demonstrates a regulatory role for myosin Vila in actin dynamics of Stereocilia", Mol. Cell. Biol., (20080000), vol. 28, pages 1702 - 12-
DESCRIPTION- PROSSER, H.M.RZADZINSKA, A.K.STEEL, K.P.BRADLEY, A., "Mosaic complementation demonstrates a regulatory role for myosin Vila in actin dynamics of stereocilia", Molecular and Cellular Biology, (20080000), vol. 28, pages 1702 - 1712-
DESCRIPTION- RAMIREZ-SOLIS RLIU PBRADLEY A, "Chromosome engineering in mice", Nature, (19950000), vol. 378, pages 6558,720 - 4-
DESCRIPTION- ZHENG et al., NAR, (19990000), vol. 27, no. 11, pages 2354 - 2360-
DESCRIPTION- RAMIREZ-SOLIS, R.DAVIS, A.C.BRADLEY, A., "Gene targeting in embryonic stem cells", Methods in Enzymology, (19930000), vol. 225, doi:10.1016/0076-6879(93)25054-6, pages 855 - 878, XP000918540
DESCRIPTION- WALLACE, H.A.C. et al., "Manipulating the mouse genome to engineering precise functional syntenic replacements with human sequence", Cell, (20070000), vol. 128, doi:10.1016/j.cell.2006.11.044, pages 197 - 209, XP002481713
DESCRIPTION- ADAMS DJQUAIL MACOX TVAN DER WEYDEN LGORICK BDSU QCHAN WIDAVIES RBONFIELD JKLAW F, "A genome-wide, end-sequenced 129Sv BAC library resource for targeting vector construction", Genomics, (20051027), vol. 86, no. 6, doi:10.1016/j.ygeno.2005.08.003, pages 753 - 8, XP005265840
DESCRIPTION- SCHLAKE, T.J. BODE, "Use of mutated FLP-recognition-target-(FRT-)sites for the exchange of expression cassettes at defined chromosomal loci", Biochemistry, (19940000), vol. 33, doi:10.1021/bi00209a003, pages 12746 - 12751, XP000616165
DESCRIPTION- BARRETT, M.T.SCHEFFER, A.BEN-DOR, A.SAMPAS, N.LIPSON, D.KINCAID, R.TSANG, P.CURRY, B.BAIRD, K.MELTZER, P.S. et al., "Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA", Proceedings of the National Academy of Sciences of the United States of America, (20040000), vol. 101, doi:10.1073/pnas.0407979101, pages 17765 - 17770, XP002630628
DESCRIPTION- LIANG, Q.CONTE, N.SKARNES, W.C.BRADLEY, A., "Extensive genomic copy number variation in embryonic stem cells", Proceedings of the National Academy of Sciences of the United States of America, (20080000), vol. 105, doi:10.1073/pnas.0805638105, pages 17453 - 17456, XP055303731
OPPOSITION- FRASER et al., "Precise excision of TTAA-specific lepidopteran transposon piggyback (IFP2) and tagalong (TFP3) from the baculovirus genome in cell lines...", Insect Molecular Biology, (19960000), vol. 5, no. 2, pages 141 - 151, XP055513309-
OPPOSITION- HASTY et al., "Gene targeting, principles, and practice in mammalian cells", Gene Targeting, A Practical Approach, Oxford, Oxford Scholarship, (20000000), pages 1 - 174, XP055869434-
OPPOSITION- Lynn Macdonald Et Al, "VELOCIGENE TECHNOLOGY EXTENDED TO HUMANIZATION OF SEVERAL MEGABASES OF COMPLEX GENE LOCI ", 1st International MUGEN Conference on Animal Models for Human Immunological Disease, Athens, Greece, Athens, Greece , (20060901), XP055304452-
OPPOSITION- MORRISON et al., "Vectors and Approaches for Eukaryotic Expression of Antibodies and Antibody Fusion Proteins", Antibody Engineering, (19950000), pages 267 - 293-
OPPOSITION- Sean Stevens, Macdonald Lynn, Murphy Andrew, Valenzuela David, Yancopoulos George, "VelocImmune: Humanization of immunoglobulin loci using VelociGene® technology", 1st International MUGEN conference on Animal Models for Human Immunological Disease, Athens, Greece, Athens, Greece , (20160901), pages 4 - 4, XP055343747-
OPPOSITION- SOSIO et al., "Assembly of large genomic segments in artificial chromosomes by homologous recombination in Escherichia coli", Nucleic Acids Res., (20010000), vol. 29, no. 7, page E37, XP002630416-
OPPOSITION- STEVENS, "Human Antibody Discovery", Pharma Focus Asia, (20080000), vol. 8, pages 72 - 74, XP003035947-
OPPOSITION- TORRES et al., "Flox-and-invert", Laboratory Protocols for Conditional Gene targeting, Oxford, (19970000), pages 37 - 41, XP055500666-
OPPOSITION- WOLTIJEN et al., "piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells", Nature, (20090000), vol. 458, pages 766 - 770, XP009139776-
OPPOSITION- QU et al., "Gene targeting of ErbB using a Cre-mediated unidirectional DNA inversion strategy", Genesis, vol. 44, doi:10.1002/dvg.20243, pages 477 - 486, XP055500670
OPPOSITION- GUAN et al., "A Review of Current Large-Scale Mouse Knockout Efforts", Genesis, (20100000), vol. 48, doi:10.1002/dvg.20594, pages 73 - 85, XP055046410
OPPOSITION- LARGAESPADA, "Transposon mutagenesis in mice", Methods Mol Biol., (20090000), vol. 530, pages 379 - 390, XP055304524
OPPOSITION- BIRLING et al., "Site-Specific Recombinases for Manipulation of the Mouse Genome", Transgenesis Techniques, Principles and Protocols, Dordrecht, (20090000), doi:10.1007/978-1-60327-019-9_16, pages 245 - 263, XP009121653
OPPOSITION- ARTHUR et al., "Gene -Targeting Vectors", Transgenesis Techniques, Principles and Protocols, Dordrecht, (20090000), doi:10.1007/978-1-60327-019-9_9, pages 127 - 144, XP055304425
OPPOSITION- OUMARD et al., "Recommended Method for Chromosome Exploitation: RMCE-based Cassette-exchange Systems in Animal Cell Biotechnology", Cytotechnology, (20060000), vol. 50, no. 1-3, doi:10.1007/s10616-006-6550-0, pages 93 - 108, XP019393904
OPPOSITION- Vlacha, V. Feketea, G., "Thrombocytosis in Pediatric Patients Is Associated with Severe Lower Respiratory Tract Inflammation", ARCHIVES OF MEDICAL RESEARCH, INSTITUTO MEXICANO DEL SEGURO SOCIAL, MEXICO, MX, MX , (20060801), vol. 37, no. 6, doi:10.1016/j.arcmed.2006.02.009, ISSN 0188-4409, pages 755 - 759, XP005530450
OPPOSITION- SORRELL et al., "Targeted modification of mammalian genomes", Biotechnology Advances, (20050000), vol. 23, doi:10.1016/j.biotechadv.2005.03.003, pages 431 - 469, XP005076498
OPPOSITION- WALLACE et al., "Manipulating the mouse genome to engineer precise functional syntenic replacements with human sequence", Cell, (20070000), vol. 128, no. 1, doi:10.1016/j.cell.2006.11.044, pages 197 - 209, XP002481713
OPPOSITION- KOTZAMANIS et al., "Construction of human artificial chromosome vectors by recombineering", Gene, (20050000), vol. 351, doi:10.1016/j.gene.2005.01.017, pages 29 - 38, XP004938395
OPPOSITION- WOODWARD et al., "piggyBac-ing models and new therapeutic strategies", Trends in Biotechnology, (20150000), vol. 33, doi:10.1016/j.tibtech.2015.06.009, pages 525 - 533, XP055513326
OPPOSITION- HOHN et al., "Elimination of selection markers from transgenic plants", Curr Opin Biotechnol, (20010000), vol. 12, doi:10.1016/S0958-1669(00)00188-9, pages 139 - 143, XP002466486
OPPOSITION- BAER et al., "Coping with kinetic and thermodynamic barriers: RMCE, an efficient strategy for the targeted integration of transgenes", Curr Opin Biotechnol., vol. 12, no. 5, doi:10.1016/S0958-1669(00)00248-2, pages 473 - 80, XP002209666
OPPOSITION- Andrew Murphy, "Veloclmmune: Immunoglobulin Variable Region Humanised Mice", Recombinant Antibodies for Immunotherapy, GB , Cambridge University Press , (20090101), pages 100 - 107, doi:10.1017/CBO9780511596773.011, ISBN 978-0-521-88732-8, XP055304492
OPPOSITION- YANCOPOULOS et al., "Preferential utilisation of the most JH-proximal VH gene segments in pre-B- cell lines", Nature, (19840000), vol. 311, doi:10.1038/311727a0, pages 727 - 733, XP055304516
OPPOSITION- RAMIREZ-SOLIS et al., "Chromosome engineering in mice", Nature, (19950000), vol. 378, doi:10.1038/378720a0, pages 720 - 724, XP001026456
OPPOSITION- MITRA et al., "Piggyback can bypass DNA synthesis during cut and paste transposition", EMBO J, (20080000), vol. 27, doi:10.1038/emboj.2008.41, pages 1097 - 1109, XP055500675
OPPOSITION- KAJI et al., "Virus-free induction of pluripotent and subsequent excision of reprogramming factors", Nature, (20090000), vol. 458, doi:10.1038/nature07864, pages 771 - 775, XP002568858
OPPOSITION- Jim Kling, "Big Pharma vies for mice", Nature Biotechnology, Nature Publishing Group US, New York, New York, (20070601), vol. 25, no. 6, doi:10.1038/nbt0607-613, ISSN 1087-0156, pages 613 - 614, XP055304499
OPPOSITION- SCOTT, "Mice with a human touch", Nature Biotechnology, (20070000), vol. 25, no. 10, doi:10.1038/nbt1007-1075, pages 1075 - 1077, XP037065829
OPPOSITION- LONBERG, "Human antibodies from transgenic animals", Nature Biotechnology, (20050000), vol. 23, no. 9, doi:10.1038/nbt1135, pages 1117 - 1125, XP055545019
OPPOSITION- Lee E-Chiang; Liang Qi; Ali Hanif; Bayliss Luke; Beasley Alastair; Bloomfield-Gerdes Tara; Bonoli Laura; Brown Richard; Campbell Jamie; Carpenter Adam; Chalk Sara; Davis Alison; England Nick; Fane-Dremucheva Alla; Franz Bettina; Germaschewski Volker; Holmes Helen; Holmes Steve; Kirby Ian; Kosmac Miha; Legent Anais; Lui Hui; Manin Anais; O'Leary Siobhan; Paterson Jemima; Sciarrillo Rocco; Speak Anneliese; Spensberger Dominik; Tuffery Laura; Waddell Nikole; Wang Wei; Wells Sophie; Wong Vivian; Wood Andrew; Owen Michael J; Friedrich Glenn A; Bradley Allan, "Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery", Nature Biotechnology, Nature Publishing Group US, New York, New York, (20140316), vol. 32, no. 4, doi:10.1038/nbt.2825, ISSN 1087-0156, pages 356 - 363, XP037135270
OPPOSITION- SCHNÜTGEN et al., "A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse", Nature Biotechnology, (20030000), vol. 21, doi:10.1038/nbt811, pages 562 - 565, XP055108504
OPPOSITION- ADAMS et al., "Mutagenic insertion and chromosome engineering resource (MICER", Nature Genetics, (20040000), vol. 36, doi:10.1038/ng1388, pages 867 - 871, XP055304429
OPPOSITION- GLASER et al., "Current issues in mouse genome engineering", Nature Genetics, (20050000), vol. 37, no. 11, doi:10.1038/ng1668, pages 1187 - 1193, XP055277100
OPPOSITION- KOKUBU et al., "A transposon-based chromosomal engineering method to survey a large cis-regulatory landscape in mice", Nature Genetics, (20090000), vol. 41, no. 8, doi:10.1038/ng.397, pages 496 - 397, XP055513298
OPPOSITION- YUSA et al., "Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon", Nature Methods, (20090000), vol. 6, no. 5, doi:10.1038/nmeth.1323, pages 363 - 369, XP055040531
OPPOSITION- IVICS et al., "Transposon-mediated genome manipulation in vertebrates", Nature Methods, (20090000), vol. 6, no. 6, doi:10.1038/nmeth.1332, pages 415 - 422, XP055032021
OPPOSITION- SHARAN et al., "Recombineering: a homologous recombination-based method of genetic engineering", Nature Protocols, (20090000), vol. 4, no. 2, doi:10.1038/nprot.2008.227, pages 206 - 223, XP001525689
OPPOSITION- WILSON et al., "piggyBac transposon-mediated gene transfer in human cells", Mol Ther, (20070000), vol. 15, doi:10.1038/sj.mt.6300028, pages 139 - 145, XP055026848
OPPOSITION- SINZELLE et al., "Transposition of a reconstructed Harbinger element into human cells and functional homology with two transposon-derived cellular genes", PNAS, (20080000), vol. 105, doi:10.1073/pnas.0707746105, pages 4715 - 4720, XP055513323
OPPOSITION- WANG et al., "Chromosomal transposition of PiggyBac in mouse embryonic stem cells", PNAS, (20080000), vol. 105, no. 27, doi:10.1073/pnas.0801017105, pages 9290 - 9295, XP055026857
OPPOSITION- MACDONALD et al., "Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes", PNAS USA, (20140000), vol. 111, no. 14, doi:10.1073/pnas.1323896111, pages 5147 - 5152, XP055126064
OPPOSITION- MURPHY et al., "Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice", PNAS USA, (20140000), vol. 111, no. 14, doi:10.1073/pnas.1324022111, pages 5153 - 5158, XP055162338
OPPOSITION- WU et al., "Double replacement: strategy for efficient introduction of subtle mutations into the murine Col1a-1 gene by homologous recombination in embryonic stem cells", Proc Natl Acad Sci USA, (19940000), vol. 91, no. 7, doi:10.1073/pnas.91.7.2819, pages 2819 - 2823, XP002074111
OPPOSITION- LUO et al., "Chromosomal transposition of a Tc1/mariner- like element in mouse embryonic stem cells", PNAS, (19980000), vol. 95, doi:10.1073/pnas.95.18.10769, pages 10769 - 10773, XP002946962
OPPOSITION- BATES et al., "Chromosomal position of a VH gene segment determines its activation and inactivation as a substrate for V(D)J recombination", JEM, (20070000), vol. 204, no. 13, doi:10.1084/jem.20071787, pages 3247 - 3256, XP055304520
OPPOSITION- NI et al., "Transposon tools hopping in vertebrates", Briefings in Functional Genomics and Proteomics, (20080000), vol. 7, doi:10.1093/BFGP/ELN049, pages 444 - 453, XP002666602
OPPOSITION- CALL et al., "A cre-lox recombination system for the targeted integration of circular yeast artificial chromosomes into embryonic stem cells", HMG, (20000000), vol. 9, doi:10.1093/hmg/9.12.1745, pages 1745 - 1751, XP002956896
OPPOSITION- Zhengyao Xu, Lee Nicholas C. O., Dafhnis-Calas Felix, Malla Sunir, Smith Margaret C. M., Brown William R. A., "Site-specific recombination in Schizosaccharomyces pombe and systematic assembly of a 400kb transgene array in mammalian cells using the integrase of Streptomyces phage ϕBT1", Nucleic Acids Research, Oxford University Press, GB, GB , (20080101), vol. 36, no. 1, doi:10.1093/nar/gkm1123, ISSN 0305-1048, pages 1 - 9, XP055500662
OPPOSITION- OBERDOERFFER et al., "Unidirectional cre-mediated genetic inversion in mice using the mutant loxP pair lox66/lox71", Nucleic Acids Research, (20030000), vol. 31, no. 22, doi:10.1093/nar/gng140, pages 1 - 7, XP002992914
OPPOSITION- DAFHNIS-CALAS et al., "Iterative in vivo assembly of large and complex transgenes by combining the activities of phiC31 integrase and Cre recombinase", Nucleic Acids Res, (20050000), vol. 33, no. 22, doi:10.1093/nar/gni192, page e189, XP002561513
OPPOSITION- GIBSON et al., "Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome", Science, (20080000), vol. 319, no. 5867, doi:10.1126/science.1151721, pages 1215 - 20, XP009101716
OPPOSITION- HASTY et al., "Target frequency and integration pattern for insertion and replacement vectors", Mol. Cell . Biol., (19910000), vol. 11, no. 9, doi:10.1128/MCB.11.9.4509, pages 4509 - 4517, XP055304430
OPPOSITION- ASKEW et al., "Site-Directed Point Mutations in Embryonic Stem Cells: a Gene -Targeting Tag-and-Exchange Strategy", Mol. Cell, (19930000), vol. 13, no. 7, doi:10.1128/MCB.13.7.4115, pages 4115 - 4124, XP000568152
OPPOSITION- STACEY et al., "Use of double-replacement gene targeting to replace the murine alpha-lactalbumin gene with its human counterpart in embryonic stem cells and mice", Mol Cell Biol, (19940000), vol. 14, doi:10.1128/MCB.14.2.1009, pages 1009 - 1016, XP000562809
OPPOSITION- ZHENG et al., "Engineering mouse chromosomes with Cre- loxP: range, efficiency, and somatic applications", Mol Cell Biol, (20000000), vol. 20, no. 2, doi:10.1128/MCB.20.2.648-655.2000, pages 648 - 655, XP003030871
OPPOSITION- STORB et al., "Physical linkage of mouse lambda genes by pulsed- field gel electrophoresis suggests that the rearrangement process favours proximate target sequences", Mol. Cell . Biol., (19890000), vol. 9, no. 2, doi:10.1128/MCB.9.2.711, pages 711 - 718, XP055304521
OPPOSITION- ADAMS et al., "Contemporary approaches for modifying the mouse genome", Physiol. Genomics, (20080000), vol. 34, doi:10.1152/physiolgenomics.90242.2008, pages 225 - 238, XP055054853
OPPOSITION- MORTUZA et al., "Immunoglobulin heavy-chain gene rearrangement in adult acute lymphoblastic leukaemia reveals preferential usage of JH-proximal variable gene segments", Blood, (20010000), vol. 97, doi:10.1182/blood.V97.9.2716, pages 2716 - 2726, XP055304512
OPPOSITION- UNGRIN et al., "Strict control of telomerase activation using Cre mediated inversion", BMC Biotechnology, (20060000), vol. 6, no. 10, doi:10.1186/1472-6750-6-10, pages 1 - 9, XP002762660
OPPOSITION- CLARK et al., "Pigs taking wing with transposon and recombinases", Genome Biology, (20070000), vol. 8, doi:10.1186/gb-2007-8-s1-s13, page S13, XP002490458
OPPOSITION- BRAULT et al., "Modeling chromosomes in mouse to explore the function of genes, genomic disorders, and chromosomal organization", PLoS Genetics, (20060000), vol. 2, no. 7, doi:10.1371/journal.pgen.0020086, pages 911 - 919, XP055255516
OPPOSITION- BODE et al., "The transgeneticist's toolbox: Novel methods for the targeted modification of eukaryotic genomes", Biological Chemistry, (20000000), vol. 381, no. 9-10, doi:10.1515/BC.2000.103, pages 801 - 813, XP002282829
OPPOSITION- MUÑOZ-LÓPEZ et al., "DNA transposons: nature and applications in genomics", Curr Genomics, (20100000), vol. 11, no. 2, doi:10.2174/138920210790886871, pages 115 - 128, XP055109912
OPPOSITION- WILLIAMS et al., "Unequal VH gene rearrangement frequency within the large VH 7183 gene family is not due to recombination signal sequence variation..", J Immunol., (20010000), vol. 167, doi:10.4049/jimmunol.167.1.257, pages 257 - 263, XP055304513
OPPOSITION- RETTER et al., "Sequence and Characterization of the Ig Heavy Chain Constant and Partial Variable Region of the Mouse Strain 129S1", J. Immunol., (20070000), vol. 179, doi:10.4049/jimmunol.179.4.2419, pages 2419 - 27, XP055268136
OPPOSITION- GONDO et al., "Next-generation gene targeting in the mouse for functional genomics", BMB Reports, (20090000), vol. 42, no. 6, doi:10.5483/BMBRep.2009.42.6.315, pages 315 - 323, XP055500658
SEARCH- NILS LONBERG, "Human antibodies from transgenic animals", NATURE BIOTECHNOLOGY, New York, (20050901), vol. 23, no. 9, doi:10.1038/nbt1135, ISSN 1087-0156, pages 1117 - 1125, XP055545019 [A] 1-17 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents